I’m unable to produce a compliant market article for this request because the required real-time verification step did not return any usable last-24-hours news items, and I cannot verify fresh biotech events from memory alone without risking inaccuracies.

Given your strict requirement to use only real, verifiable news from the last 24 hours, the responsible editorial choice is to withhold a fabricated analysis rather than infer a trend. If you want, I can still help in one of two ways: I can draft a publication-ready biotech market note once you provide a specific headline or company name, or I can produce a historically grounded sector analysis that is not limited to the last 24 hours.